April 24, 2024 COA Program Concludes Successful Annual Meeting On April 17 and 18, C-Path's Clinical Outcome Assessment (COA) Program hosted its Annual Meeting in Rockville, MD...
April 23, 2024 Clinical Outcome Assessment — Initial Public Discussion In this presentation from C-Path's rare and orphan disease program, you will see...
September 26, 2024-September 27, 2024 2024 Complex In Vitro Model: Qualification Framework Public Workshop Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PSTC) is delighted to announce the second...
April 22, 2024 Unlocking the Capabilities of Large Language Models for Accelerating Drug Development Recent breakthroughs in natural language processing (NLP), particularly in large language models (LLMs), offer substantial...
September 9, 2024-September 11, 2024 C-Path Hosts its Inaugural Global Impact Conference We are thrilled to invite you to the inaugural Critical Path Institute Global Impact Conference taking place this September...
C-Path Forms Data Collaboration with International Niemann-Pick Disease Registry (INPDR) to Propel Niemann-Pick Disease Research Forward TUCSON, Ariz. April 17, 2024 — Critical Path Institute (C-Path), a leader in advancing rare disease research, today announced a
C-Path Appoints Dr. Amanda Klein as Executive Director for CPLD and CPA-1 Consortia TUCSON, Ariz., April 17, 2024 — Critical Path Institute (C-Path) today announced the appointment of Amanda Klein, Pharm.D., as E
April 10, 2024 Critical Path Institute Announces New Board Members Bonnie A. Allin and Louis Breton Critical Path Institute (C-Path) today announced the appointments of Bonnie A. Allin and Louis Breton to its Board of Directors.
April 1, 2024 C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
June 16, 2024-June 20, 2024 Join C-Path at DIA Global 2024 C-Path CEO Klaus Romero will be a panelist in two sessions at the upcoming...